Ascelia Pharma AB (OSTO:ACE) Total Liabilities : kr29.25 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Total Liabilities?

Ascelia Pharma AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr29.25 Mil.

Ascelia Pharma AB's quarterly Total Liabilities declined from Sep. 2023 (kr21.80 Mil) to Dec. 2023 (kr12.74 Mil) but then increased from Dec. 2023 (kr12.74 Mil) to Mar. 2024 (kr29.25 Mil).

Ascelia Pharma AB's annual Total Liabilities increased from Dec. 2021 (kr25.66 Mil) to Dec. 2022 (kr37.71 Mil) but then declined from Dec. 2022 (kr37.71 Mil) to Dec. 2023 (kr12.74 Mil).

Ascelia Pharma AB Total Liabilities Historical Data

The historical data trend for Ascelia Pharma AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Total Liabilities Chart

Ascelia Pharma AB Annual Data

Trend

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

11.35

19.32

25.66

37.71

12.74

Ascelia Pharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															35.59	33.62	21.80	12.74	29.25

Ascelia Pharma AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ascelia Pharma AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.568	+	(0.176	+	1.6653345369377E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	12.74

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	87.072	-	74.328
	=	12.74

Ascelia Pharma AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11.214	+	(18.031	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	29.25

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	92.126	-	62.881
	=	29.25

Ascelia Pharma AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ascelia Pharma AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascelia Pharma AB (OSTO:ACE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

7ZA:Germany

Address

Hyllie Boulevard 34, Malmo, SWE, SE-215 32

Website

https://www.ascelia.com

Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Ascelia Pharma AB (OSTO:ACE) Headlines

No Headlines